Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is a prevalent hereditary kidney disease and the fourth most common cause of kidney failure. Patients may be aware of their condition from an early age or discover it unexpectedly, with varying levels of familial knowledge about the disease. This chronic condition presents significant challenges for healthcare professionals. The study aimed to investigate how people with ADPKD experience their participation in a dedicated ADPKD clinic and to investigate their support needs in managing their disease in everyday life. Methods: A qualitative phenomenological descriptive study was conducted, involving semi-structured telephone interviews with patients who attended a newly established dedicated ADPKD clinic between March and April 2023. The data were analyzed using Malterud’s principles of systematic text condensation. Results: In total, 18 out of 22 patients agreed to participate in the interviews. Six themes emerged from the interviews. Participants expressed feelings of uncertainty about their future and highlighted the necessity for personalized care tailored to their individual circumstances. They reported challenges in coping with emotions associated with the disease and sought assistance in making difficult decisions. Maintaining control over their health and illness was a significant theme, alongside a desire for increased knowledge about their condition. Conclusion: Our study supports existing knowledge in this area. In this study, the participants experienced satisfaction with the dedicated ADPKD clinic, feeling well informed, listened to, and more at ease after the check-up. Investing in a dedicated ADPKD clinic could help alleviate the uncertainty that many people with ADPKD experience.

1.
Cornec-Le Gall
E
,
Alam
A
,
Perrone
RD
.
Autosomal dominant polycystic kidney disease
.
Lancet
.
2019
;
393
(
10174
):
919
35
.
2.
Tong
A
,
Rangan
GK
,
Ruospo
M
,
Saglimbene
V
,
Strippoli
GF
,
Palmer
SC
, et al
.
A painful inheritance-patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research
.
Nephrol Dial Transplant
.
2015
;
30
(
5
):
790
800
.
3.
Baker
A
,
King
D
,
Marsh
J
,
Makin
A
,
Carr
A
,
Davis
C
, et al
.
Understanding the physical and emotional impact of early-stage ADPKD: experiences and perspectives of patients and physicians
.
Clin Kidney J
.
2015
;
8
(
5
):
531
7
.
4.
Torres
VE
,
Chapman
AB
,
Devuyst
O
,
Gansevoort
RT
,
Perrone
RD
,
Koch
G
, et al
.
Tolvaptan in later-stage autosomal dominant polycystic kidney disease
.
N Engl J Med
.
2017
;
377
(
20
):
1930
42
.
5.
Irazabal
MV
,
Abebe
KZ
,
Bae
KT
,
Perrone
RD
,
Chapman
AB
,
Schrier
RW
, et al
.
Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial
.
Nephrol Dial Transplant
.
2017
;
32
(
11
):
1857
65
.
6.
Heiwe
S
,
Bjuke
M
.
“An evil heritage”: interview study of pain and autosomal dominant polycystic kidney disease
.
Pain Manag Nurs
.
2009
;
10
(
3
):
134
41
.
7.
Simms
RJ
,
Thong
KM
,
Dworschak
GC
,
Ong
AC
.
Increased psychosocial risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease
.
Nephrol Dial Transplant
.
2016
;
31
(
7
):
1130
40
.
8.
Oberdhan
D
,
Palsgrove
AC
,
Cole
JC
,
Harris
T
.
Caregiver burden of autosomal dominant polycystic kidney disease: a qualitative study
.
Kidney Med
.
2023
;
5
(
2
):
100587
.
9.
Oberdhan
D
,
Schaefer
F
,
Cole
JC
,
Palsgrove
AC
,
Dandurand
A
,
Guay-Woodford
L
.
Polycystic kidney disease-related disease burden in adolescents with autosomal dominant polycystic kidney disease: an international qualitative study
.
Kidney Med
.
2022
;
4
(
3
):
100415
.
10.
Danish Nephrological Society
.
Autosomal dominant polycystisk nyresygdom
. In:
Rapport
;
2012
. [cited 2024 Jun 20] Available from: https://nephrology.dk/Publikationer/ADPKD-rapport%20endelig%20udgave%206.6.pdf
11.
De Rechter
S
,
Bammens
B
,
Schaefer
F
,
Liebau
MC
,
Mekahli
D
.
Unmet needs and challenges for follow-up and treatment of autosomal dominant polycystic kidney disease: the paediatric perspective
.
Clin Kidney J
.
2018
;
11
(
Suppl 1
):
i14
26
.
12.
EAF co-chairs
;
Harris
T
,
Sandford
R
;
EAF members
;
Roundtable participants
.
European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD Forum and Multispecialist Roundtable participants
.
Nephrol Dial Transplant
.
2018
;
33
(
4
):
563
73
.
13.
Birkler
J
.
Videnskabsteori: en grundbog
.
Copenhagen
:
Kbh Munksgaard
;
2021
.
14.
Thisted
J
.
Forskningsmetode i praksis: projektorienteret videnskabsteori og forskningsmetodik
.
Copenhagen
:
Kbh Munksgaard
;
2024
.
15.
Kvale
S
,
Brinkmann
S
.
Interviews: learning the craft of qualitative research interviewing
.
London
:
Sage Publications
;
2014
.
16.
Tong
A
,
Sainsbury
P
,
Craig
J
.
Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups
.
Int J Qual Health Care
.
2007
;
19
(
6
):
349
57
.
17.
Malterud
K
.
Systematic text condensation: a strategy for qualitative analysis
.
Scand J Public Health
.
2012
;
40
(
8
):
795
805
.
18.
Gittus
M
,
Harris
T
,
Ong
AC
.
Patient perspectives on ADPKD
.
Adv Kidney Dis Health
.
2023
;
30
(
3
):
294
302
.
19.
Havas
K
,
Douglas
C
,
Bonner
A
.
Meeting patients where they are: improving outcomes in early chronic kidney disease with tailored self-management support (the CKD-SMS study)
.
BMC Nephrol
.
2018
;
19
(
1
):
279
.
You do not currently have access to this content.